Larisa V Yurchenko

Randomized, placebo-controlled phase II trial of heat-killed<i>Mycobacterium vaccae</i>(Longcom batch) formulated as an oral pill (V7)

Y. Efremenko, Dmytro Butov, Natalia D Prihoda et al. · Human Vaccines & Immunotherapeutics · 2013 · 27 citations · Full text

Heat-killed Mycobacterium Vaccae, Tuberculosis Prevention, Immunology +27

Randomized, Placebo-Controlled Phase II Trial of Heat-Killed <i>Mycobacterium Vaccae</i> (Immodulon Batch) Formulated as an Oral Pill (V7)

Dmytro Butov, Y. Efremenko, Natalia D Prihoda et al. · Immunotherapy · 2013 · 24 citations

Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Journal of Vaccines & Vaccination · 2010 · 20 citations · Full text

Adjunct Oral Immunotherapy in Patients with Re-Treated, Multidrug-Resistant or HIV-Coinfected TB

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Immunotherapy · 2010 · 16 citations

Clinical Symptoms, Immunodeficiencies, Tuberculosis Prevention +19

Clinical Validation of Sublingual Formulations of Immunoxel (Dzherelo) as an Adjuvant Immunotherapy in Treatment of TB Patients

Y. Efremenko, Olga V. Arjanova, Natalia D Prihoda et al. · Immunotherapy · 2012 · 16 citations

Immunohematology, Tb Drugs, Immunodeficiencies +22